Compare Ecopetrol SA (EC) vs ResMed Inc. (RMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ecopetrol SA vs ResMed Inc. — how do they compare? Ecopetrol SA trades at $16.04 (market cap $30.44B), while ResMed Inc. trades at $202.84 (market cap $28.80B). The key difference: Ecopetrol SA and ResMed Inc. are close in size by market cap, and Ecopetrol SA pays the higher dividend (4.06%). Which is the better fit depends on your goals.
| EC | RMD | |
|---|---|---|
Market Cap | $30.44B | $28.80B |
Sector | Energy | Health |
52-Week High | $16.58 | $293.73 |
52-Week Low | $8.29 | $182.82 |
Enterprise Value | $58.23B | $27.99B |
Dividend Yield | 4.06% | 1.21% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ecopetrol SA
Ecopetrol SA is a vertically integrated oil company with operations in Latin America and the United States Gulf Coast. Based out of Colombia, the company explores, develops, and conducts production activities in various countries. Ecopetrol works as the primary operator or partner in a joint venture, in a host of assets held onshore and offshore. Along with production, the company refines and markets crude oils and byproducts produced from its fields. Crude products are moved by Ecopetrol through a series of pipelines throughout Colombia, along with a network of third-party production centers and facilities.
Read more on EC →About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →
